Stephen Karmazyn, BA

Stephen Karmazyn is a writer for Profit Confidential, where he focuses on reporting breaking news in the technology and emerging industries.

Throughout his career as a journalist, Karmazyn has written on tech for a variety of publications, including The Financial Post, The Globe and Mail, and The Ottawa Business Journal. He served as the web editor for Techopia, a tech-centered newsblog focused on emerging start-up companies.

Get to know Stephen…

What first sparked your interest in tech?

Near the end of my undergrad, I spent some time interning at the Financial Post. My very first story was on Elon Musk’s SpaceX trying to land a used rocket on a floating drone-operated barge in the middle of a gulf. Besides being infinitely fascinating and an absolutely joy to write about, the story was my very first pitch and published piece. The next day Shopify went public and that absorbed the remainder of my time at FP.

What makes tech reporting different than other news?

Cutting-edge tech is having a profound effect on almost every aspect of our day-to-day lives, and tomorrow always brings something new to the table. Essentially, each article about tech acts as a potential preview for what life may look like in the near future.

What interests you about technology stocks?

Technology stocks are great to watch because the market determines in a very concrete way which devices will define our future. By following the emerging tech companies, you get to see in real time which innovations fly and which others will falter.

Stephen Karmazyn's Articles

Pfizer Stock & Moderna Stock Show Promise as Coronavirus Stocks Finally, some good news. Not one, but two vaccines have been making headlines for being 90%-plus effective at countering COVID-19, giving hope to people everywhere that the pandemic-related lockdown may not be, contrary to our worst fears, eternal.…

Watch Tesla Stock in 2021 The year is coming to a close (thankfully) and we're now looking ahead to 2021. Aside from the COVID-19 issue, next year the stock market is going to be very interesting for one major reason: Joe Biden. Biden is now the president-elect (although…

Pfizer Inc. Scores Huge Win The COVID-19 pandemic rages on, and people the world over are fixated on one thing: a cure or a vaccine. Pfizer Inc. (NYSE:PFE) saw its share price soar after the company announced that its trial coronavirus vaccine was proving to be very effective. Pfizer…

U.S. Marijuana Stocks Marijuana stocks have been getting battered in 2020. Or at least, every pot stock that isn't American has been getting battered. U.S. marijuana stocks have, in fact, actually seen pretty impressive gains over the past year, all things considered. With that in mind, it's easy to…

Apple Inc Gets Bold Listen, I know Apple Inc (NASDAQ:AAPL) isn't an under-the-radar stock; AAPL stock has been among the most celebrated stocks for decades now. Apple stock, in fact, is widely considered one of the top tech stock powerhouses of the last 40 or so years. But as with…

U.S. Marijuana Legalization Gains Steam Election day is behind us and a lot remains uncertain—except for one thing: marijuana stocks have won big. Federal U.S. marijuana legalization has long been a forgone conclusion, but with five more states legalizing pot in some form, we can expect to see…

Netflix Stock vs. Snowflake Stock There's been no shortage of hot tech stocks in 2020. The COVID-19 pandemic, for all its manifold horrors, has been, not only less aggressive toward tech stocks, but in certain instances, downright friendly. Which brings us to two hot tech stocks in 2020—Netflix…

Regeneron Stock Gains Political Favor There have been few securities more exciting than pharma stocks in 2020. That's because, in case you missed it, we're currently suffering under the tyranny of a global pandemic. Not only has it killed hundreds of thousands of people, but it's also brought…

Canadian Marijuana Stocks Surge? This has not been an easy year for marijuana stocks—especially for pot stocks operating in Canada exclusively. While still the first major economy to legalize marijuana for all uses, Canada has since fallen behind in terms of marijuana industry excitement (which, to be fair,…

Marijuana Stock Gains off Vermont Legalization It's safe to say that 2020 hasn't been easy for marijuana stocks. To be fair, 2020 hasn't been easy for, well, everything and everyone, but marijuana stocks have been particularly hurt during this COVID-19-stricken year. But some of that malaise is now…

Nikola Stock Highly Volatile This year has been anything but predictable. One stock, however, has nearly matched 2020 when it comes to being unpredictable: Nikola Corporation (NASDAQ:NKLA). Nikola stock seemingly came onto the scene out of nowhere, announcing that it planned to see huge revenue in the upcoming…

Tesla Stock Scores Another Victory The wins keep piling up for Tesla Inc (NASDAQ:TSLA). In a year largely marked by disappointment and frustration (both on and off the stock market), Tesla stock has been able to over deliver, if anything. TSLA stock is up an astounding 435% year-to-date, and…

Snowflake IPO Doubles in 24 Hours What has already been a crazy year for tech stocks just got a little crazier with the initial public offering of Snowflake Inc (NYSE:SNOW) recently becoming the largest software IPO of all time. Snowflake stock doubled its value in the span of a day…

Pfizer Stock Gains on Vaccine Announcement For what feels like months now, we've been closely following the race to develop a COVID-19 vaccine. From among the top pharmaceutical stocks looking to bring an end to the pandemic, one has made a big announcement that puts it ahead of…

ORCL Just Became a Social Media Stock In what has been an otherwise rather boring year in the social media stock space, a huge move has totally upended the status quo: Oracle Corporation (NYSE:ORCL) is no longer just a cloud stock, but now also lays claim to being one…

Will There Be Stock Market Stimulus? The stock market, having been largely resilient since the initial COVID-19 downturn, has experienced its first hiccup post-recovery. With the pandemic still raging, there's the consistent threat that there could be more stock market tumult on the way due to the coronavirus,…

Pharma Stocks on the Rise The number one priority of governments around the globe this year is to develop a COVID-19 vaccine. As a result, pharmaceutical stocks, a.k.a. pharma stocks, have seen huge gains due to their being pretty much designated as the best possible and most direct…